Orchard Rx Limited IPO Research Information

Orchard Rx Limited IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Orchard Rx Limited, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Orchard Rx Limited	ORTX - NASDAQ	$14.00-$16.00	$14.00	$17.00	14.3 million ADSs	10/31/2018
Underwriter(s): J.P. Morgan, Goldman Sachs, Cowen
Co-Manager(s): Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2018-10-04 Terms Added 2018-10-23

Orchard Rx Limited Quote & Chart - Click for current quote - ORTX

About Orchard Rx Limited (adapted from Orchard Rx Limited prospectus):
They are a commercial-stage, fully-integrated biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ORTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.